register

News & Trends - MedTech & Diagnostics

Baxter to expand local manufacturing with NSW Government investment

Health Industry Hub | May 12, 2021 |

MedTech News: Baxter Healthcare, a local manufacturer of Australian made medical products, announced a major expansion of its Western Sydney advanced manufacturing facility.

Premier Gladys Berejiklian said the $250 million program from Investment NSW was an opportunity for the state to invest in its future prosperity by nurturing industries, technology and stimulating job creation.

As Australia’s only local manufacturing facility for IV medical fluids, Baxter will expand its manufacturing operations in Old Toongabbie, NSW, to strengthen Australia’s national medical supply chain and exports of Australian Made medicines to the Oceania Region.

With the funding support from NSW Government’s Job Plus program, Baxter will install a new additional production filling line for its intravenous (IV) medical fluids.

The expanded facility is expected to create approximately 80 new advanced manufacturing jobs, in addition to jobs created due to construction.

General Manager for Baxter Australia & New Zealand, Steven Flynn said “Baxter is proud to partner with the NSW Government to invest in our modern manufacturing operations in Western Sydney and create jobs in the local medtech sector.

“This major expansion of Baxter’s medical manufacturing facility will help to strengthen our national supply chain resilience and support continued export growth of Australian Made medicines.

“Baxter intravenous (IV) medicines are the backbone of medication delivery in the ICU, oncology wards, emergency rooms and operating theatres across Australia and the South Pacific.”

“As Australia’s only local manufacturer of IV medical fluids, Baxter is committed to supporting our hospitals and healthcare professionals with reliable supply of medicines during the pandemic and beyond,” Mr Flynn added.

Minister for Jobs, Investment, Tourism and Western Sydney Stuart Ayres said supporting the growth of medical technology and healthcare innovation protected lives as well as the economy.

“The pandemic put a spotlight on the value of these high-growth, essential industries and backing their growth is crucial to ensure our economy is fuelled by sustainable, knowledge-based jobs that are here for the long run,” Mr Ayres stated.


News & Trends - MedTech & Diagnostics

Medtech, academia and government unite: Breaking down silos to deliver the power and promise of digital health to patients

Health Industry Hub | December 11, 2023 |

MedTech & Diagnostics News: In an interview with Health Industry Hub, Annette Schmiede, CEO of Digital Health Cooperative Research Centre […]

More


News & Trends - MedTech & Diagnostics

Two-decade evolution of robotic surgery in Australia's medical landscape

Two-decade evolution of robotic surgery in Australia’s medical landscape

Health Industry Hub | December 11, 2023 |

MedTech & Diagnostics News: In the past two decades, what was once deemed impossible in surgery has now become a […]

More


News & Trends - Pharmaceuticals

World-first in IVF: Merging AI and genomics to optimise treatment response

World-first in IVF: Merging AI and genomics to optimise treatment response for Australians

Health Industry Hub | December 11, 2023 |

Pharma News: A world-first Australian IVF study exploring genome sequencing has garnered enthusiastic reception from its collaborative research partners. Securing […]

More


News & Trends - Pharmaceuticals

PBS listing marks first oral therapy for childhood arthritis

PBS listing marks first oral therapy for childhood arthritis

Health Industry Hub | December 11, 2023 |

Pharma News: The first oral Janus kinase (JAK) inhibitor, Pfizer’s Xeljanz (tofacitinib), has been listed on the Pharmaceutical Benefits Scheme […]

More


This content is copyright protected. Please subscribe to gain access.